REDMOND, WA, January 2, 2024 — Pattern Computer®, Inc. (“Pattern” or “the Company”) today announced that Mark R. Anderson, Chairman and CEO, is scheduled to present at the Biotech Showcase™ 2024 investor forum, taking place January 8-10, 2024 at the Hilton San Francisco Union Square, San Francisco, CA. Mr. Anderson will provide an update on Pattern’s technological and strategic advancements in Explainable AI (XAI™) Wednesday January 10, 2023, at 3:15 p.m. PT. Registered attendees of the Biotech Showcase can view Pattern’s presentation live, and also access a recorded version. With 24×7 on-demand access, attendees can view recorded presentations at their convenience when scheduling does not allow viewing during the main event week. To register for the conference: https://informaconnect.com/biotech-showcase/registration-options/.
During the conference and other events, Pattern will conduct one-on-one meetings with investors and potential partners, showcasing the Company’s business and clinical development strategy, recent corporate achievements, and anticipated milestones. To schedule a one-on-one meeting with Pattern, please contact Denyse Hudson at denyse@patterncomputer.com.
Mr. Anderson commented, “We are pleased to be participating in the Biotech Showcase 2024 Conference, an investor conference focused on driving advances in therapeutic development by providing a sophisticated networking platform for executives and investors that fosters investment and partnership opportunities. The conference takes place each year in San Francisco during the course of one of the industry’s largest gatherings and busiest weeks, centered around the JP Morgan Healthcare Conference 2024, in which Pattern will also be participating.
“Pattern is on the verge of capitalizing on the work that our technical team has been perfecting over the past eight years, including combination cancer drug discoveries and diagnostic advances against four of the top five cancers, in which we are looking to partner with firms to bring these drugs into clinical trials; our Third Wave AI technology, the Pattern Discovery Engine™; ProSpectral™, a game-changing medical diagnostic tool and research instrument; and our TrueXAI™ products within Explainable AI. We are at an inflection point, moving from a quasi-academic research organization focused on generating assets, to a company fully focused on capitalizing on those assets.” “We are delighted that Pattern will be joining us in San Francisco and presenting at Biotech Showcase this year,” said Sara Demy, CEO of Demy-Colton. “Biotech Showcase is a prime opportunity for life science entrepreneurs and investors to come together to discover the potential of innovative technologies that will drive the future of drug discovery.”
About Biotech Showcase 2024
Biotech Showcase, produced by Demy-Colton and EBD Group, is an investor and networking conference devoted to providing private and public biotechnology and life sciences companies with an opportunity to present to, and meet with, investors and pharmaceutical executives in one place. Investors and biopharmaceutical executives from around the world gather at Biotech Showcase during this bellwether week which sets the tone for the coming year. Now in its 16th year, this well-established, highly respected conference features multiple tracks of presenting companies, plenary sessions, workshops, networking, and an opportunity to schedule one-to-one meetings. Biotech Showcase is produced by Demy-Colton and EBD Group. Both organizations have a long history of producing high-quality programs that support the biotechnology and broader life sciences industry.
About Pattern
Pattern Computer, Inc., a Seattle-area company, uses its proprietary Pattern Discovery Engine™ to solve the most important and intractable problems in business and medicine. Its proprietary mathematical techniques can find complex patterns in very-high-order data that have eluded detection by much larger systems.
As the Company applies its computational platform to the challenging fields of drug discovery and diagnostics, it is also making major Pattern Discoveries for partners in other sectors, including biotech, materials science, aerospace manufacturing, veterinary medicine, air traffic operations, and finance. www.patterncomputer.com.
CONTACT: Laura Guerrant-Oiye (808) 960-2642 – laura@patterncomputer.com
The foregoing contains statements about Pattern Computer’s future that are not statements of historical fact. These statements are “forward looking statements” for purposes of applicable securities laws and are based on current information and/or management’s good faith belief as to future events. The words “believe,” “expect,” “anticipate,” “project,” “should,” “could,” “will,” and similar expressions signify forward-looking statements. Forward-looking statements should not be read as a guarantee of future performance. By their nature, forward-looking statements involve inherent risk and uncertainties, which change over time, and actual performance could differ materially from that anticipated by any forward-looking statements. Pattern Computer undertakes no obligation to update or revise any forward-looking statement.
Copyright © 2024 Pattern Computer Inc. All Rights Reserved. Pattern Computer, Inc., Pattern Discovery Engine, PatternBio, TrueXAI, and ProSpectral are trademarks of Pattern Computer Inc. or its subsidiaries. Other trademarks may be trademarks of their respective owners.